microdosing on tirzepatide for Peri Weight: Help? Tirzepatide vs Semaglutide for Microdosing

GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) are contraindicated during breastfeeding per UK Summary of Product Characteristics No weight loss injection currently has regulatory approval for use whilst breastfeeding in the UK Transfer into breast milk and effects on nursing infants remain unknown due to absence of human studies Appetite suppression from these medications may compromise maternal nutrition needed for adequate milk production Safe alternatives include gradual dietary modification, regular physical activity, and NHS weight management programmes Women should defer weight loss medications until breastfeeding is completed and seek GP advice for postpartum weight concerns Table of Contents Weight Loss Injections and Breastfeeding: Key Safety Considerations Types of Weight Loss Injections and Their Use During Lactation Potential Risks to Breastfed Infants Alternative Approaches to Postpartum Weight Management When to Seek Medical Advice About Weight Loss While Breastfeeding Frequently Asked Questions Weight Loss Injections and Breastfeeding: Key Safety Considerations Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), have become increasingly popular for weight management

Ormond describes

Intestinal Nat Med 2022;28:315-24

Its important to talk to your healthcare provider about the best plan for making the switch safely

it includes the opportunity cost of supply disruption to patients on continuous dosing regimens

Oral tablets must be taken on an empty stomach 30 minutes before food, and peak blood levels appear within one to three hoursa faster but shorter-lived effect that some patients find easier to tolerate